TABLE 1.
Method | Primer | Sequence (5′–3′) (restriction site) |
---|---|---|
PCRa | OUTER | GCAATATTTGGAGGATCCGACAAT |
R147 | TCTCTTGATGGCTGGATTATTCAT | |
R59 | ACTGAGCGGAAGGTGCTGGGCAGT | |
R98 | TTGGAAAACCCATTCTTGAGG | |
F (−1209) | GTATGGTACCCTCTGCATTGGGACTG (KpnI) | |
F (−575) | GTATGGTACCCACGCCGCACTCGA (KpnI) | |
F (−118) | GTATGGTACCTCTCCGCAGCTCC (KpnI) | |
F (−82) | GTATGGTACCGCTAGAGCATGCGC (KpnI) | |
F (−19) | GTATCTCGAGCCGGCGACTGCGCTGG (XhoI) | |
R (−19) | GACTAAGCTTGATCACCGCAAACGCT (HindIII) | |
R (−59) | GACTAAGCTTCTGCGCACTGCGCA (HindIII) | |
Site-directed mutagenesisb | NRF-1 mut1 | GCCGCGGCTAGAAAATGCGCAGTGCGCAGGGCCGGCTCGAAGCGC |
NRF-1 mut2 | GCCGCGGCTAGAGCATGAACAGTGCGCAGGGCCGGCTCGAAGCGC | |
Methylation status of hIDE core promoter | CpG-F | GGAAAGTCTGGGTGCTGGCTC |
CpG-R | TTAAGTGCTGAATCACCACTTTGCAAC | |
EMSA | IDE WT | CCGCGGCTAGAGCATGCGCAGTGCGCAGGG |
IDE MUT | CCGCGGCTAGAAAATGAACAGTGCGCAGGG |
a Restriction site sequences are shown in italics and underlined.
b Mutated bases are shown in bold and underlined.